myDNAge Epigenetic Clock: The Original Horvath Clock Made Consumer-Accessible

Built by the epigenetics company behind the gold-standard research reagents, myDNAge brings Steve Horvath’s original epigenetic clock directly to consumers, with the unique option of testing from a urine sample.

Presented By Our Partners

In 2013, Steve Horvath at UCLA published the paper that launched the field of epigenetic aging. By identifying 353 CpG sites across the human genome whose methylation patterns change with remarkable consistency as organisms age, Horvath created the first epigenetic clock: a mathematical model that predicts biological age from DNA methylation data with a median error of approximately 3.6 years. The original Horvath clock was not just a curiosity. It revealed that biological age, as measured by methylation patterns, often diverges significantly from chronological age, and that the direction and magnitude of this divergence predicts health outcomes, mortality risk, and susceptibility to age-related disease. Every subsequent epigenetic clock, from Hannum to PhenoAge to GrimAge to DunedinPACE, builds on the foundation Horvath established. myDNAge, developed by Zymo Research, a leading manufacturer of epigenetics research reagents and kits used in thousands of academic laboratories worldwide, brings the Horvath clock directly to consumers. It is the only major consumer biological age test produced by a company whose core business is supplying the tools that epigenetics researchers use to generate the data these clocks are built on.

What Is myDNAge?

myDNAge is an at-home biological age test that measures DNA methylation at the 353 CpG sites used in Horvath’s original pan-tissue epigenetic clock. The test is available from Zymo Research at a price range of $299 to $499 depending on the package and testing options selected. Users collect a sample at home and mail it to Zymo’s CLIA-certified laboratory for processing.

The most distinctive feature of myDNAge is its sample type flexibility. While most epigenetic age tests require a blood sample (finger prick), myDNAge offers the option of urine-based testing in addition to blood. Urine collection is entirely non-invasive, requiring no skin puncture of any kind, which makes myDNAge the most accessible epigenetic age test for users who are uncomfortable with blood collection or finger-prick procedures.

The report provides a biological age estimate based on the Horvath clock, a comparison to chronological age, and contextual information about what the result means within the framework of aging research. Zymo recommends retesting every 3 to 12 months for longitudinal tracking of biological age changes in response to lifestyle modifications. The platform is more focused on delivering accurate methylation data than on providing personalized coaching or intervention recommendations.

The Science Behind It: The Horvath Clock and Pan-Tissue Aging

The Horvath clock’s defining scientific feature is its pan-tissue applicability. Unlike later clocks that were trained on blood data alone, Horvath’s original algorithm was trained on methylation data from 51 different cell types and tissues, including brain, liver, kidney, breast, lung, and blood. This means the Horvath clock provides a biological age estimate that reflects whole-organism aging rather than the aging of a single tissue type. The 353 CpG sites were identified through a regularized regression analysis of over 8,000 samples, and the resulting clock achieved a correlation of 0.96 between predicted and actual age across training and validation datasets.

The 2018 study by Levine et al. in Aging developed PhenoAge as a more clinically predictive alternative by incorporating clinical biomarkers into the training process. The 2021 study by McCrory et al. in The Journals of Gerontology demonstrated that GrimAge outperformed Horvath’s clock (along with Hannum and PhenoAge) in predicting walking speed, frailty, polypharmacy, cognitive performance, and all-cause mortality in 490 Irish adults followed for 10 years. These findings indicate that while the Horvath clock was the pioneering achievement that made the field possible, newer clocks have surpassed it in predictive power for specific clinical outcomes.

This does not make the Horvath clock obsolete. Its pan-tissue design means it captures a broader, more fundamental dimension of aging than tissue-specific clocks. It also means that the Horvath clock can be applied to a wider range of sample types, which is why myDNAge can offer urine-based testing: the clock’s algorithm is not dependent on blood-specific methylation patterns. For consumers who want a biological age measurement grounded in the most historically validated and widely cited epigenetic clock in the scientific literature, the Horvath clock remains a legitimate and informative choice. That is the science. Here is how myDNAge applies it.

What myDNAge Does Well

The urine collection option is myDNAge’s most distinctive practical feature. For consumers who are needle-averse, have difficulty with finger-prick blood collection, or simply prefer a completely non-invasive process, urine-based epigenetic testing removes the last physical barrier to biological age measurement. No other consumer epigenetic age test offers this option.

Zymo Research’s position as a leading supplier of epigenetics reagents to the research community provides a unique credibility advantage. The company’s core business is manufacturing the DNA extraction kits, bisulfite conversion reagents, and methylation analysis tools used by thousands of laboratories worldwide. This means Zymo’s laboratory processes are built on the same quality infrastructure that supports peer-reviewed research. Users who value analytical rigor and laboratory expertise may find this pedigree more reassuring than that of newer, consumer-first companies.

The use of the original Horvath clock provides a well-understood baseline. Because the Horvath clock has been validated across hundreds of published studies spanning over a decade, its properties, error margins, and population-level predictive accuracy are thoroughly documented. Users and researchers know exactly what they are getting: a biological age estimate from the most cited and replicated epigenetic clock in the literature.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

Pricing, Access, and Practical Realities

myDNAge pricing ranges from $299 to $499 depending on the package selected. The basic single-test option is at the lower end; multi-test or premium packages that include additional analysis or faster processing are at the higher end. No subscription is required, and results are accessible through a secure online portal.

Both blood (finger prick) and urine collection options are available. Urine collection requires no special preparation beyond following the included instructions. Results are typically delivered within 4 to 8 weeks. No physician order is required. myDNAge is not currently listed as HSA or FSA eligible, and it carries no FDA clearance. Results are classified as informational wellness data processed in a CLIA-certified laboratory.

Zymo Research is a well-established company with a stable business model rooted in research reagent sales, which provides a degree of corporate stability that pure consumer testing startups may not match. However, myDNAge’s consumer platform and user experience are less polished than those of TruDiagnostic or Elysium, reflecting Zymo’s research-first heritage.

Who myDNAge Is Best For

myDNAge is ideal for users who want a biological age measurement from the most historically validated epigenetic clock (Horvath) administered by a company with deep expertise in epigenetics laboratory science. It suits users who prefer urine-based collection for comfort, convenience, or medical reasons. Researchers and scientifically literate consumers who want a clean, well-characterized methylation measurement without additional layers of proprietary algorithms or supplement ecosystem integration will appreciate myDNAge’s straightforward approach. Users who value laboratory pedigree and analytical rigor over consumer experience design will find Zymo’s research heritage reassuring.

Those who should choose alternatives include users who want the most comprehensive multi-algorithm epigenetic analysis, as TruDiagnostic TruAge Complete provides OMICmAge, DunedinPACE, GrimAge, PhenoAge, and Horvath in a single report, along with organ-specific ages and immune cell composition. Anyone seeking the strongest mortality-prediction power should note that GrimAge (available through TruDiagnostic) has been shown to outperform the Horvath clock for clinical outcome prediction. Users who want the most consumer-friendly experience with polished dashboards and personalized action plans may prefer Elysium or Chronomics. Those seeking genetic (not epigenetic) testing need an entirely different product category.

How myDNAge Compares

TruDiagnostic TruAge Complete ($499) is the most comprehensive option, offering five named clocks including Horvath. myDNAge provides the Horvath clock alone at a potentially lower price point, making it a more focused but less comprehensive choice. Elysium Index ($299) offers a saliva-based test with a proprietary biological age algorithm and pace of aging metric, competing at the same price as myDNAge’s entry-level offering but with a different sample type and algorithmic approach.

GlycanAge ($299 to $499) measures biological age through an entirely different biomarker (IgG glycan patterns), providing immune-specific aging data that is complementary to all methylation-based tests. Chronomics ($299 to $499) emphasizes longitudinal tracking with trend visualization. Among methylation-based tests at the $299 price point, myDNAge’s unique advantages are urine collection and the Horvath clock’s historical validation; its disadvantage is a narrower algorithmic scope and less polished consumer experience.

Limitations and Open Questions

The Horvath clock, while historically pioneering, has been surpassed by newer clocks for clinical outcome prediction. The McCrory et al. 2021 study found that Horvath age acceleration was not significantly predictive of any of the nine clinical outcomes examined, while GrimAge predicted eight of nine. This does not mean the Horvath clock provides no value, but users should understand that more recently developed clocks offer stronger predictive power for mortality, frailty, and disease risk.

Urine-based methylation analysis, while more convenient, introduces considerations about sample quality. Urine contains cells shed from the urinary tract, and the cellular composition can vary based on hydration status, urinary tract health, and collection methodology. While the Horvath clock’s pan-tissue design accommodates different cell types, the consistency of urine-based results across repeated tests has less published validation than blood-based measurements.

myDNAge’s consumer platform and reporting are less developed than TruDiagnostic’s or Elysium’s. The report provides a biological age number and basic context but lacks the depth of interpretation, personalized action plans, and longitudinal tracking tools that competitors offer. For users who want data and can interpret it independently, this is not a limitation. For users who need guidance on what to do with their biological age result, the simpler reporting may leave them wanting more. The standard caveats about all epigenetic age testing apply: 3 to 5 year individual-level error margins, evolving science, and the unproven causal link between methylation reversal and lifespan extension.

What This Means for Your Health

Every epigenetic clock tells you something about where you stand on the aging continuum. The Horvath clock, the original and most widely validated, tells you how old your cells appear based on the most fundamental, tissue-agnostic methylation patterns that accumulate with age. Within Healthcare Discovery‘s longevity framework, this information connects directly to the Four Shadows: accelerated biological aging is the common upstream driver of cardiovascular disease, cancer, neurodegenerative decline, and metabolic dysfunction.

The Five Pillars of Nutrition, Sleep, Movement, Breathwork, and Mindset are the primary interventions for influencing biological age. Research consistently shows that each of these pillars affects DNA methylation patterns: caloric quality influences metabolic methylation signatures; sleep duration and regularity affect circadian methylation cycles; exercise intensity drives methylation changes in muscle, cardiovascular, and immune tissue; breathwork and meditation reduce stress-related methylation acceleration; and social connection and purpose protect against the epigenetic signature of chronic loneliness.

The practical recommendation: myDNAge is a solid, scientifically grounded choice for users who want a biological age measurement from the clock that started the field, delivered by a laboratory with deep epigenetics expertise. If you want maximum predictive power and comprehensive analysis, TruDiagnostic remains the category leader. If you want the most accessible collection process (urine), myDNAge is uniquely positioned. The most important principle transcends the choice of test: measure your biological age, commit to the Five Pillars, and remeasure. The trajectory matters more than any single data point.

Frequently Asked Questions

What is the Horvath epigenetic clock?
The Horvath clock, published in 2013 by Steve Horvath at UCLA, was the first epigenetic clock capable of accurately predicting biological age from DNA methylation data. It analyzes methylation patterns at 353 specific CpG sites across the genome and was trained on data from 51 different cell types and tissues, making it the only pan-tissue epigenetic clock. It achieves a median age prediction error of approximately 3.6 years across populations. myDNAge uses this specific clock for its biological age measurements.

Can I use urine instead of blood for myDNAge?
Yes. myDNAge is the only major consumer biological age test that offers urine-based collection. Because the Horvath clock was trained on data from multiple tissue types (not just blood), it can generate valid biological age estimates from the cells present in urine. Urine collection is entirely non-invasive and requires no finger prick or blood draw. The blood collection option is also available for users who prefer it.

Is the Horvath clock still accurate compared to newer clocks?
The Horvath clock remains a validated and accurate measure of biological age, with over a decade of replication across hundreds of published studies. However, newer clocks like GrimAge and DunedinPACE have demonstrated stronger predictive power for specific clinical outcomes (mortality, frailty, walking speed). The McCrory et al. 2021 study found GrimAge predicted 8 of 9 clinical outcomes while the Horvath clock predicted none in that specific cohort. The Horvath clock’s advantage is its pan-tissue applicability and massive validation history.

Who makes myDNAge?
myDNAge is produced by Zymo Research, a leading manufacturer of epigenetics research reagents including DNA extraction kits, bisulfite conversion reagents, and methylation analysis tools used in thousands of academic and clinical laboratories worldwide. Zymo’s core business in research reagent supply gives the company deep expertise in the laboratory science underlying epigenetic age measurement. The test is processed in Zymo’s CLIA-certified laboratory.

How does myDNAge compare to TruDiagnostic TruAge?
myDNAge ($299 to $499) provides biological age based on the original Horvath clock from blood or urine. TruDiagnostic TruAge Complete ($499) provides five clock algorithms (OMICmAge, DunedinPACE, GrimAge, PhenoAge, and Horvath), organ-specific ages, immune cell composition, and deeper reporting. TruDiagnostic offers significantly more data per test. myDNAge offers urine collection, laboratory pedigree from Zymo Research, and a potentially lower entry-level price point.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.